This is the authors' abstract. We don't add key points for this paper.
Background. Psoriasis is a systemic immune-mediated inflammatory disease with a high risk of comorbid conditions, among which metabolic syndrome (MS) is of particular importance. The association of MS with plaque psoriasis has been best studied, while data on its prevalence in rare clinical variants, particularly palmoplantar pustular psoriasis (PPP), are limited. Aim. To study the prevalence of metabolic syndrome and its components in young patients with various forms of psoriasis. Materials and methods. The study included 106 patients with psoriasis, divided into three groups: Group 1: 31 patients with palmoplantar pustular psoriasis, Group 2: 37 patients with plaque psoriasis complicated with psoriatic arthritis, and Group 3: 38 patients with plaque psoriasis without arthritis. All patients underwent an assessment of clinical and demographic parameters, skin disease severity using the PASI index, blood lipid profile parameters, fasting glucose and insulin levels, and calculation of the HOMA-IR insulin resistance index. Metabolic syndrome was diagnosed using unified international criteria and the criteria of the All-Russian Scientific Society of Cardiologists (VNOC). Results. The prevalence of metabolic syndrome according to international criteria was 42.0% in the PPP group, 37.8% in patients with plaque psoriasis and psoriatic arthritis, and 26.3% in patients with plaque psoriasis without arthritis. According to the All-Russian Society of Cardiologists criteria, similar figures were 45.2, 40.5, and 31.6%, respectively. Patients with PPP and patients with psoriatic arthritis had statistically significantly higher levels of insulin and HOMA-IR index compared with patients with isolated plaque psoriasis. Insulin levels and HOMA-IR index were statistically significantly higher in groups 1 and 2 (8.0 [5.47; 13.6] and 11.55 [9.90; 16.08]; 1.99 [1.22; 3.93] and 2.89 [2.43; 4.53], respectively) compared with group 3 (3.56 [2.29; 6.63]; 0.83 [0.67; 1.66]). Conclusions. Hyperinsulinemia and insulin resistance in patients with PPP and MS likely reflect the existing pathogenetic differences between pustular and plaque psoriasis. The findings may be useful for clinical practice when screening for metabolic disorders in young patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Turchik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: